Henning Jann

2.5k total citations
59 papers, 1.3k citations indexed

About

Henning Jann is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Henning Jann has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Epidemiology, 50 papers in Oncology and 36 papers in Neurology. Recurrent topics in Henning Jann's work include Neuroendocrine Tumor Research Advances (58 papers), Lung Cancer Research Studies (45 papers) and Neuroblastoma Research and Treatments (36 papers). Henning Jann is often cited by papers focused on Neuroendocrine Tumor Research Advances (58 papers), Lung Cancer Research Studies (45 papers) and Neuroblastoma Research and Treatments (36 papers). Henning Jann collaborates with scholars based in Germany, Italy and France. Henning Jann's co-authors include Bertram Wiedenmann, Ulrich‐Frank Pape, Martin Koch, Guido Rindi, Christoph Röcken, Jacqueline Müller‐Nordhorn, Marianne Pavel, Uta Berndt, Angelina Bockelbrink and Stefan N. Willich and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Henning Jann

54 papers receiving 1.3k citations

Peers

Henning Jann
Rossella Bettini Italy
Wouter T. Zandee Netherlands
Michael Böhmig Germany
Igor Latich United States
Scott K. Sherman United States
Anna Sowa‐Staszczak Poland
Piero Ferollà Italy
Yi‐Zarn Wang United States
Nicole Brighi Italy
Christopher Russell United States
Rossella Bettini Italy
Henning Jann
Citations per year, relative to Henning Jann Henning Jann (= 1×) peers Rossella Bettini

Countries citing papers authored by Henning Jann

Since Specialization
Citations

This map shows the geographic impact of Henning Jann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Jann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Jann more than expected).

Fields of papers citing papers by Henning Jann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henning Jann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Jann. The network helps show where Henning Jann may publish in the future.

Co-authorship network of co-authors of Henning Jann

This figure shows the co-authorship network connecting the top 25 collaborators of Henning Jann. A scholar is included among the top collaborators of Henning Jann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henning Jann. Henning Jann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jann, Henning, et al.. (2024). Emergency surgery influences oncological outcome in small intestinal neuroendocrine tumors. Scandinavian Journal of Surgery. 113(4). 303–313.
2.
Meng, Qing H., Þorvarður R. Hálfdánarson, Joshua A. Bornhorst, et al.. (2024). Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids—The CASPAR Study. Clinical Cancer Research. 30(24). 5559–5567. 1 indexed citations
3.
4.
5.
Mohr, Raphael, Henning Jann, Christian S. Fischer, et al.. (2023). Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms. Journal of Cancer Research and Clinical Oncology. 149(12). 10925–10933. 5 indexed citations
6.
Mogl, Martina T., Robert Öllinger, Henning Jann, et al.. (2022). Differenzierte Therapiestrategie bei Lebermetastasen gastro-entero-pankreatischer Neuroendokriner Neoplasien. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 147(3). 270–280. 1 indexed citations
7.
Geisler, Lukas, Raphael Mohr, Joeri Lambrecht, et al.. (2021). The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors. International Journal of Molecular Sciences. 22(16). 8569–8569. 13 indexed citations
8.
Detjen, Katharina, Lukas Geisler, Pamela Riemer, et al.. (2021). Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms. Cancers. 13(17). 4463–4463. 6 indexed citations
9.
Fehrenbach, Uli, Timo Alexander Auer, Henning Jann, et al.. (2021). Automatized Hepatic Tumor Volume Analysis of Neuroendocrine Liver Metastases by Gd-EOB MRI—A Deep-Learning Model to Support Multidisciplinary Cancer Conference Decision-Making. Cancers. 13(11). 2726–2726. 13 indexed citations
10.
Özdirik, Burcin, Henning Jann, Philip Bischoff, et al.. (2021). PD-L1 – inhibitors in neuroendocrine neoplasia. Medicine. 100(1). e23835–e23835. 10 indexed citations
11.
Özdirik, Burcin, Antonin Kayser, Lynn Jeanette Savic, et al.. (2020). Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review. Cancers. 12(3). 733–733. 22 indexed citations
12.
Mogl, Martina T., et al.. (2020). Influence of Gender on Therapy and Outcome of Neuroendocrine Tumors of Gastroenteropancreatic Origin: A Single-Center Analysis. Visceral Medicine. 36(1). 20–27. 6 indexed citations
13.
Mohr, Raphael, Lukas Geisler, Alexander Wree, et al.. (2020). Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors. PLoS ONE. 15(12). e0244504–e0244504. 4 indexed citations
14.
Özdirik, Burcin, Lukas Geisler, Raphael Mohr, et al.. (2020). Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies. Journal of Clinical Medicine. 9(6). 1647–1647. 10 indexed citations
15.
Özdirik, Burcin, Raphael Mohr, Lukas Geisler, et al.. (2020). Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study. Journal of Clinical Medicine. 9(9). 2881–2881. 8 indexed citations
16.
Detjen, Katharina, Linda Hammerich, Burcin Özdirik, et al.. (2020). Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions. Neuroendocrinology. 111(3). 217–236. 16 indexed citations
17.
Jann, Henning, et al.. (2019). Evaluating hepatotoxic effects of chemotherapeutic agents with gadoxetic-acid-enhanced magnetic resonance imaging. European Journal of Radiology. 124. 108807–108807. 2 indexed citations
18.
Pschowski, René, Ulrich‐Frank Pape, Gerhard Fusch, et al.. (2016). Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia. Neuroendocrinology. 104(2). 135–144. 5 indexed citations
19.
Jann, Henning, Timm Denecke, Martin Koch, et al.. (2013). Impact of Octreotide Long-Acting Release on Tumour Growth Control as a First-Line Treatment in Neuroendocrine Tumours of Pancreatic Origin. Neuroendocrinology. 98(2). 137–143. 41 indexed citations
20.
Jann, Henning, Stephanie Roll, Anne Couvelard, et al.. (2011). Neuroendocrine tumors of midgut and hindgut origin: Tumor‐node‐metastasis classification determines clinical outcome. Cancer. 117(15). 3332–3341. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rossella Bettini Breakdown of academic impact, for papers by Wouter T. Zandee Breakdown of academic impact, for papers by Michael Böhmig Breakdown of academic impact, for papers by Igor Latich Breakdown of academic impact, for papers by Scott K. Sherman Breakdown of academic impact, for papers by Anna Sowa‐Staszczak Breakdown of academic impact, for papers by Piero Ferollà Breakdown of academic impact, for papers by Yi‐Zarn Wang Breakdown of academic impact, for papers by Nicole Brighi Breakdown of academic impact, for papers by Christopher Russell
Rankless by CCL
2026